Rational medication in clinical practice for COVID-19 guided by Shanghai expert consensus. TT -, --"".
Chinese Journal of Clinical Infectious Diseases
; 14(1):7-12, 2021.
Artigo
em Chinês
| EMBASE | ID: covidwho-2306475
ABSTRACT
The outbreak of COVID-19 occurred in January 2020, the epidemic is still rampant around the world. The Shanghai Expert Consensus on Comprehensive Treatment and Management of Corona Virus Disease 2019 was issued in early March 2020, which provided the guidance of the standardized treatment and rational medication for COVID-19. The administration of " four agents (glucocorticoids, heparin, high-dose vitamin C, Interferon-kappa) and one peptide (thymic peptide)" recommended by the consensus is the key to successfully block and treat critical illness.Copyright © 2021 Chinese Medical Association
Texto completo:
Disponível
Coleções:
Bases de dados de organismos internacionais
Base de dados:
EMBASE
Tipo de estudo:
Estudo prognóstico
Idioma:
Chinês
Revista:
Chinese Journal of Clinical Infectious Diseases
Ano de publicação:
2021
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS